CRUK 4 Year PhD Studentships: The Cancer Research UK Manchester Institute is delighted to announce the availability of CRUK 4 Year PhD Studentships for 2024. This presents a unique opportunity for passionate individuals to contribute to cutting-edge cancer research at our institute.
Summary Table:
| Application Deadline | Friday, 8 December 2023 – 1700 hrs (GMT) |
|---|---|
| Interview Date | Thursday, 18 January 2024 |
| Stipend | £21,000 GBP per annum (non-taxable) |
| Duration | 4 Years |
| Location | Paterson New Building, Withington, Manchester, M20 4BX |
Study Area: PhD studentships are available in various research groups focusing on cancer biology, immunology, and therapy. Explore diverse topics such as cancer immune escape, leukaemia therapy, and melanoma biology.
Scholarship Description:
Cancer Research UK Manchester Institute – CRUK 4 Year PhD Studentships 2024
Successful applicants will receive a non-taxable annual stipend of £21,000 GBP, covering bench and tuition fees (applicable for home and international students) for the full 4-year duration. Affiliation for registration and graduation will be with the University of Manchester, UK.
Eligibility: Applications are open to candidates of all nationalities with a strong academic track record. Applicants should hold or expect to graduate with a First or upper-second class undergraduate honours degree in a relevant subject. Laboratory research experience in cancer is advantageous but not mandatory.
Required Documents: Interested candidates should submit the following documents:
- Application Form
- CV
- Academic Transcripts
- Personal Statement
- Two References
How to Apply: To apply for a CRUK 4 Year PhD Studentship, visit the official Cancer Research UK Manchester Institute website and complete the application process. Clearly indicate your interest in the specific project title you wish to pursue.
Last Date: The application deadline is Friday, 8 December 2023 – 1700 hrs (GMT). Don’t miss this opportunity to be part of groundbreaking cancer research. Apply now and contribute to the advancement of knowledge in cancer biology and therapy.
